BRWM
BPMC

B. Riley Wealth Management’s Blueprint Medicines BPMC Stock Holding History

B. Riley Wealth Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,060
Closed -$231K – 437
2020
Q4 		$231K Buy
+2,060
New +$217K 0.03% 307

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

B. Riley Wealth Management's BPMC Position: Q1 2021 in Review

B. Riley Wealth Management sold out of Blueprint Medicines (BPMC) in Q1 2021, closing a stake of 2,060 shares — an estimated $231K sold.

B. Riley Wealth Management first reported a position in BPMC in Q4 2020 and held it in 1 quarter. The position peaked at $231K in Q4 2020. 263 funds tracked by Wall St. Rank hold BPMC as of Q1 2021.

  • B. Riley Wealth Management reported no remaining Blueprint Medicines position as of Q1 2021 after selling out during the quarter.
  • B. Riley Wealth Management sold 2,060 Blueprint Medicines shares in Q1 2021, an estimated $231K.
  • B. Riley Wealth Management first reported a position in Blueprint Medicines in Q4 2020 and held it in 1 quarter.
  • B. Riley Wealth Management's Blueprint Medicines position peaked at $231K in Q4 2020.
  • 263 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2021.

Based on B. Riley Wealth Management's 13F filing for Q1 2021, filed 17 May 2021.